NEW YORK / Oct 08, 2024 / Business Wire / Oscar Health, Inc. (“Oscar” or the “Company”) (NYSE: OSCR), a leading healthcare technology company, will release its third quarter 2024 financial results before the market opens on Thursday, November 7, 2024.
Management will review these results in a conference call beginning at 8:00 AM (ET). The call-in number and webcast link are as follows:
Live Call: 1.888.596.4244
Conference ID: 7768132
Webcast Link
The call will be archived and available on Oscar’s investor relations website (ir.hioscar.com) following November 7, 2024 for a period of 90 days.
About Oscar Health
Oscar Health, Inc. (“Oscar”) is a leading healthcare technology company built around a full stack technology platform and a relentless focus on serving our members. We have been challenging the status quo in the healthcare system since our founding in 2012, and are dedicated to making a healthier life accessible and affordable for all. Oscar offers Individual & Family plans and health technology solutions that power the healthcare industry through +Oscar. Our technology drives superior experiences, deep engagement, and high-value clinical care, earning us the trust of approximately 1.6 million members, as of June 30, 2024.
| Last Trade: | US$15.89 |
| Daily Change: | 0.61 3.99 |
| Daily Volume: | 8,525,970 |
| Market Cap: | US$3.360B |
February 04, 2025 November 07, 2024 August 22, 2024 August 07, 2024 | |
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORE
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MORE
